Suppr超能文献

常染色体显性遗传性骨硬化症 2 型的影像学、骨密度和疾病严重程度。

Radiographic imaging, densitometry and disease severity in Autosomal dominant osteopetrosis type 2.

机构信息

Department of Radiology & Imaging Sciences, Indiana University School of Medicine, 1701 N. Senate Blvd, Radiology Dept, MH1238A, Indianapolis, IN, 46202, USA.

Indiana Center for Musculoskeletal Health, Indiana University, Indianapolis, IN, USA.

出版信息

Skeletal Radiol. 2021 May;50(5):903-913. doi: 10.1007/s00256-020-03625-3. Epub 2020 Oct 3.

Abstract

OBJECTIVE

To characterize relationships between quantitative computed tomography bone mineral density measurements and other qualitative and quantitative imaging measures, as well as clinical metrics, in patients with autosomal dominant osteopetrosis type 2 (ADO2).

MATERIALS AND METHODS

Clinical and radiologic parameters of 9 adults and 3 children with autosomal dominant osteopetrosis type 2 were assessed including lumbar spine quantitative computed tomography (QCT), radiographic skeletal survey (skull base thickening; Erlenmeyer flask deformity; endobone pattern; and spine density pattern (endplate sclerosis, "anvil" appearance, or diffuse sclerosis)), dual-energy x-ray absorptiometry (DXA), tibial peripheral quantitative computed tomography (pQCT) volumetric bone mineral density (vBMD), bone turnover markers, and bone marrow failure or visual impairment.

RESULTS

The skeletal parameter most divergent from normal was lumbar spine QCT Z-score (+ 3.6 to + 38.7). Lumbar QCT Z-score correlated positively with pQCT tibial diaphysis vBMD (Pearson correlation r = 0.73, p = 0.02) and pQCT tibial metaphysis vBMD (r = 0.87, p < 0.01). A trend towards positive lumbar QCT Z-score correlation with serum P1NP/CTX ratio (r = 0.54, p = 0.10) and lumbar DXA Z-score (r = 0.55, p = 0.10) were observed. Bone marrow failure and vision impairment occurred in those with most severe quantitative and qualitative measures, while those with less severe radiographic features had the lowest QCT Z-scores.

CONCLUSION

Lumbar spine QCT provided the most extreme skeletal assessment in ADO2, which correlated positively with other radiologic and clinical markers of disease severity. Given the quantification of trabecular bone and greater variation from normal with wider range of values, lumbar QCT Z-scores may be useful to determine or detect impact of future treatments.

摘要

目的

描述 2 型常染色体显性遗传性骨硬化症(ADO2)患者定量 CT 骨密度测量值与其他定性和定量成像指标以及临床指标之间的关系。

材料与方法

评估了 9 名成人和 3 名儿童 ADO2 患者的临床和放射学参数,包括腰椎定量 CT(QCT)、放射性骨骼检查(颅底增厚;瓶颈畸形;内骨模式;和脊柱密度模式(终板硬化、“铁砧”外观或弥漫性硬化))、双能 X 线吸收法(DXA)、胫骨外周定量 CT(pQCT)容积骨密度(vBMD)、骨转换标志物以及骨髓衰竭或视力损害。

结果

最偏离正常的骨骼参数是腰椎 QCT Z 评分(+3.6 至+38.7)。腰椎 QCT Z 评分与 pQCT 胫骨骨干 vBMD 呈正相关(Pearson 相关 r=0.73,p=0.02)和 pQCT 胫骨干骺端 vBMD(r=0.87,p<0.01)。观察到腰椎 QCT Z 评分与血清 P1NP/CTX 比值(r=0.54,p=0.10)和腰椎 DXA Z 评分(r=0.55,p=0.10)呈正相关趋势。骨髓衰竭和视力损害发生在定量和定性测量最严重的患者中,而那些影像学特征较轻的患者的 QCT Z 评分最低。

结论

腰椎 QCT 对 ADO2 患者的骨骼评估最具极端性,与疾病严重程度的其他放射学和临床标志物呈正相关。由于定量了小梁骨,并且由于值的范围较宽,变化较大,因此腰椎 QCT Z 评分可能有助于确定或检测未来治疗的影响。

相似文献

1
Radiographic imaging, densitometry and disease severity in Autosomal dominant osteopetrosis type 2.
Skeletal Radiol. 2021 May;50(5):903-913. doi: 10.1007/s00256-020-03625-3. Epub 2020 Oct 3.
2
Association between bone indices assessed by DXA, HR-pQCT and QCT scans in post-menopausal women.
J Bone Miner Metab. 2016 Nov;34(6):638-645. doi: 10.1007/s00774-015-0708-9. Epub 2015 Aug 21.
6
Clinical Significance of DXA and HR-pQCT in Autosomal Dominant Osteopetrosis (ADO II).
Calcif Tissue Int. 2018 Jan;102(1):41-52. doi: 10.1007/s00223-017-0332-x. Epub 2017 Oct 10.
8
Computed Tomography Diagnostic of Uncommon Case of Osteopetrosis in 80-Year-Old Man-Case Report.
Medicina (Kaunas). 2020 Oct 2;56(10):518. doi: 10.3390/medicina56100518.

引用本文的文献

1
Effect of Allele-Specific Clcn7 siRNA Delivered Via a Novel Nanocarrier on Bone Phenotypes in ADO2 Mice on 129S Background.
Calcif Tissue Int. 2024 Jul;115(1):85-96. doi: 10.1007/s00223-024-01222-3. Epub 2024 May 11.
2
Osteopetrosis in the pediatric patient: what the radiologist needs to know.
Pediatr Radiol. 2024 Jun;54(7):1105-1115. doi: 10.1007/s00247-024-05899-4. Epub 2024 Mar 14.
3
Autosomal Dominant Osteopetrosis (ADO) Caused by a Missense Variant in the TCIRG1 Gene.
J Clin Endocrinol Metab. 2024 Jun 17;109(7):1726-1732. doi: 10.1210/clinem/dgae040.
5
Unusual Cortical Phenotype After Hematopoietic Stem Cell Transplantation in a Patient With Osteopetrosis.
JBMR Plus. 2022 Apr 29;6(6):e10616. doi: 10.1002/jbm4.10616. eCollection 2022 Jun.

本文引用的文献

1
Interferon Gamma-1b Does Not Increase Markers of Bone Resorption in Autosomal Dominant Osteopetrosis.
J Bone Miner Res. 2019 Aug;34(8):1436-1445. doi: 10.1002/jbmr.3715. Epub 2019 May 13.
2
Cortical or Trabecular Bone: What's the Difference?
Am J Nephrol. 2018;47(6):373-375. doi: 10.1159/000489672. Epub 2018 May 22.
3
Osteopetroses, emphasizing potential approaches to treatment.
Bone. 2017 Sep;102:50-59. doi: 10.1016/j.bone.2017.02.002. Epub 2017 Feb 4.
6
Bone Mineral Density and Microarchitecture in Patients With Autosomal Dominant Osteopetrosis: A Report of Two Cases.
J Bone Miner Res. 2016 Mar;31(3):657-62. doi: 10.1002/jbmr.2715. Epub 2015 Oct 20.
7
Osteopetrosis: radiological & radionuclide imaging.
Indian J Nucl Med. 2015 Jan-Mar;30(1):55-8. doi: 10.4103/0972-3919.147544.
8
Axial QCT: clinical applications and new developments.
J Clin Densitom. 2014 Oct-Dec;17(4):438-48. doi: 10.1016/j.jocd.2014.04.119. Epub 2014 May 28.
9
Clinical and Radiological Findings of Autosomal Dominant Osteopetrosis Type II: A Case Report.
Case Rep Dent. 2013;2013:707343. doi: 10.1155/2013/707343. Epub 2013 Oct 24.
10
Osteopetrosis: genetics, treatment and new insights into osteoclast function.
Nat Rev Endocrinol. 2013 Sep;9(9):522-36. doi: 10.1038/nrendo.2013.137. Epub 2013 Jul 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验